Array BioPharma Inc. (NASDAQ:ARRY) Quarterly EPS Estimate At $-0.22

0

The EPS estimate of Array BioPharma Inc. (NASDAQ:ARRY) for period quarter ended 2016-12-31 is $-0.22.

The EPS estimates posted seven and 30 days ago were $-0.22 and $-0.22 correspondingly. Even though the EPS forecasts stated 60 and 90 days ago were $-0.22 and $-0.22 respectively. The deviation in EPS forecast from 7 days ago is 0%.

The EPS revisions on positive side in the last 7 days were 0 and downside revisions were 0. The number of positive revisions of EPS in the last 30 and 60days were 0 and 0 respectively, while for 90 and 120 days, the count was 0 and 0.

The number of negative revisions of EPS in the last 30 and 60days were 0 and 1 while for 90 and 120 days, the count was 1 and 1.

EPS revisions upgrade and downgrade in the last 18 days were 0 and 0 correspondingly.

Earnings Surprises

The mean EPS forecast immediately prior to the actual earnings release for the period ended 4 is $-0.22 based on 6 EPS estimates. The EPS reported on 2016-08-04 was $-0.17. The EPS surprise came at $-0.02, or -13.33%. The standard deviation of given EPS estimates was $0.13.

Quarterly Sales Estimates

The arithmetic mean of estimated annual sales of Array BioPharma Inc. (NASDAQ:ARRY) is $56.32 and the median was $58.71. The estimate is reported by 3 analysts for the fiscal 2017.

The highest annual estimate is $67.1 and lowest sales target is $43.15. This results in a standard deviation of $12.152.

Almost 3 have revised sales forecast on upside over the past week and 3 have downgraded forecasts. The mean estimate deviation from the past week is 0%.

Nearly 3 have revised sales forecast on upside over the past month and 3 have downgraded forecasts. The mean estimate deviation from the past week is 0%.

Just about 3 have revised sales forecast on upside over the quarter and 3 have downgraded forecasts. The mean estimate deviation from the past week is 133.499%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 11 times, 1 visits today)